Pharma Reviews: Intas emerges as the dark horse of Indian pharma

This is the second largest acquisition by an Indian pharma company abroad after Lupin's Rs 5,600 crore acquisition of Gavis last year in the US.
Read more: Intas emerges as the dark horse of Indian pharma